pad

Survival as Discussed at GI Symposium

Combined radiation and chemotherapy following the complete removal of invasive pancreatic adenocarcinoma can prolong patient survival for years, according to the results of a retrospective study presented January 22, 2007 at the Gastrointestinal Cancers Symposium in Orlando, Florida.

The median overall survival was 1.6 years among those who received no adjuvant therapy (n=180); 2.1years among those who received radiation and chemotherapy (n=246); and 2.9 years among those treated with radiation and chemotherapy plus a second round of chemotherapy (n=28).

After 5 years, the overall survival was 17%, 28% and 34%, respectively.

Remember we are NOT Doctors and have NO medical training.

This site is like an Encylopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.